Jim is the Chief Business Officer for Oxular. He is an accomplished and seasoned business development and strategy executive with over 20 years of creating value for pharma/biotech companies and their stakeholders. His prior work experience includes extensive experience as CBO at Rubius Therapeutics (a Flagship company focused on red blood cell therapies for oncology and auto-immune), Janssen, Alcon/Novartis and executive leadership roles at several boutique investment banks. Jim built and led the business development and M&A teams at Alcon for approximately 10 years where he was responsible for external growth strategies for its three global franchises in surgical, pharma, and consumer.